Results 41 to 50 of about 958,470 (300)

Damage Detection and Quantification Using Transmissibility Coherence Analysis

open access: yesShock and Vibration, 2015
A new transmissibility-based damage detection and quantification approach is proposed. Based on the operational modal analysis, the transmissibility is extracted from system responses and transmissibility coherence is defined and analyzed.
Yun-Lai Zhou   +3 more
doaj   +1 more source

Damage Detection in Beam-like Structures Applying Finite Volume Method [PDF]

open access: yesJournal of Rehabilitation in Civil Engineering, 2017
In this article, a damage location in beam like-structure is determined using static and dynamic data obtained applying the finite volume method. The modification of static and dynamic displacement due to damage is applied to establish an indicator for ...
Benyamin Mohebi   +2 more
doaj   +1 more source

A new modal-based damage location indicator [PDF]

open access: yes, 2014
Vibration-based damage detection techniques use the change in modal data as an indicator to assess damages in the structure. Knowing the structural dynamic characteristics of the healthy and damaged structure, the estimation of the damage location and ...
Abdel Wahab, Magd   +3 more
core  

Damage detection and quantification in composite beam structure using strain energy and vibration data [PDF]

open access: yes, 2017
10.1088/1742-6596/842/1/012027Journal of Physics: Conference ...
A Bouazzouni   +12 more
core   +2 more sources

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi   +20 more
wiley   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?

open access: yesBMJ Paediatrics Open, 2020
We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms.
Jelena Oulasvirta   +5 more
doaj   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy